Redeye sees a Q3 report matching our expectations on both sales and EBITA.
Redeye updates on Evolution post Q3-results which were close to our expectations.
Redeye provides an update on Gasporox following its Q3 2024 report, which was below expectations but...
Redeye updates its estimates and valuation following ADDvise releasing its Q3 2024 report, which bro...
Redeye provides an update following Iconovo’s Q3 report.
Fiskars' Q3 adjusted EBIT was in line with LSEG Data & Analytics consensus.
Redeye comments on the Q3 report from Lifeclean. Sales and results deviated from our expectations ne...
Q3 EBIT -27% vs cons but orders +31% vs cons Positive Q4 guidance and longer-term outlook reiterated...
Redeye comments on Invisio’s Q3-results which were largely in line with our expectations while the o...
NOI +17% y-o-y and in-line with ABGSCe (+0.4%) Positive value changes (0.
EcoRub publicerade den 24 oktober 2024 bolagets delårsrapport för det tredje kvartalet år 2024 och v...
Dovre Q3 results came in mixed relative to our estimates in the sense that Renewable Energy grew a l...
Solteq had lowered its guidance ahead of the earnings report and the net sales decline of 6.
SRV's net sales in Q3 amounted to EUR 183.5m, slightly above our estimate of EUR 179.
Vitrolife continues to improve its organic growth, and the company has delivered two quarters with c...
Redeye retains its positive view of Fortnox following a solid Q3 report that meets our expectations.
Redeye leaves an initial comment following the Q3 report published by Magle this morning.
Sales and ARR in line with ABGSCe Limited consensus estimate revisions are likely Strong margin due ...
Fiskars’ Q3 adjusted EBIT of EUR 24.3m came 1% above LSEG Data & Analytics consensus expectations.
Redeye notes that Gasporox's report came in below Redeye Estimates (RRe) across the board while prod...
